Zobrazeno 1 - 10
of 54
pro vyhledávání: '"эффективность затрат"'
Publikováno v:
Журнал инфектологии, Vol 14, Iss 5, Pp 69-77 (2023)
One of the main causes of acute gastroenteritis in children under 5 years of age is rotavirus infection (RVI). Vaccines against RVI significantly reduce the incidence. Aim. To evaluate the cost-effectiveness of mass vaccination of children with a 5-v
Externí odkaz:
https://doaj.org/article/a616edac98b94f99b774da64b55b910b
Autor:
A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, I. S. Namazova-Baranova, S. N. Avdeev, V. A. Korshunov, M. P. Kostinov, G. I. Ignatova, E. V. Blinova, A. V. Kontsevaya, R. V. Shepel, I. Yu. Drozdova, O. M. Drapkina
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 5, Pp 78-88 (2022)
Relevance. Patients with diabetes mellitus have an increased risk of developing various infections, including those of the lower respiratory tract. Immunization with anti-pneumococcal vaccines reduces pneumonia-related hospitalizations and deaths.Aim
Externí odkaz:
https://doaj.org/article/97b4b8fcdfd544fd9cbc17028df96921
Publikováno v:
Журнал инфектологии, Vol 13, Iss 4, Pp 113-120 (2021)
Generalized forms of invasive meningococcal desease (IMD) are very dangerous because they have a high mortality rate.The aim of the work was to assess the cost-effectiveness of meningococcal vaccination of infants with the 4-valent MenACWY-D conjugat
Externí odkaz:
https://doaj.org/article/907979db3197430f95cb0669315d7c33
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 18, Iss 5, Pp 7-20 (2021)
Objective: complex assessment of clinical and economic effectiveness as well as saving of the state budget assets within the therapy of patients with sepsis/septic shock based on different technologies of blood purification.Methods. Evaluation of d
Externí odkaz:
https://doaj.org/article/e8411bc21a484ee2874c2a7d2d42a5e1
Autor:
A. V. Rudakova, S. M. Kharit, I. V. Babachenko, L. N. Konovalova, S. V. Rychkova, A. N. Uskov, Yu. V. Lobzin
Publikováno v:
Журнал инфектологии, Vol 13, Iss 3, Pp 114-119 (2021)
Varicella is a significant burden on society and the healthcare system.Objective: to analyze the cost effectiveness of universal vaccination of children against varicella.Material and methods. The analysis was carried out from the perspective of the
Externí odkaz:
https://doaj.org/article/ee8840abe2ea414b89db3b94585bf130
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 18, Iss 6, Pp 39-44 (2020)
Relevance. Vaccination of people at high risk against pneumococcal infection with a 13-valent conjugate vaccine (PCV13) can significantly reduce the corresponding incidence and mortality.The aim of the work was to assess the pharmacoeconomic aspects
Externí odkaz:
https://doaj.org/article/cfa008291f9f4cf1ad8bd9698fe40a1a
Autor:
A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, O. M. Drapkina, S. N. Avdeev, L. Yu. Drozdova, G. L. Ignatova, I. S. Koroleva, V. A. Korshunov, M. P. Kostinov
Publikováno v:
Журнал инфектологии, Vol 11, Iss 4, Pp 6-18 (2019)
The aim. of the work was to evaluate the cost-effectiveness of vaccination with the 13-vaIent pneumococcal conjugate vaccine (PCV13) and its combination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) of immunocompetent adult patients
Externí odkaz:
https://doaj.org/article/59f56c6affb247daac351f85f2273056
Autor:
Alla V Rudakova, Vladimir V Strugov
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 29-32 (2019)
Background. Current treatment of relapsed/refractory chronic lymphocytic leukemia implies the use of regimens that include innovative drugs such as ibrutinib and a combination of venetoclax with rituximab. Herewith the combination of venetoclax with
Externí odkaz:
https://doaj.org/article/3d924aa74df24ca49dc3939e6a60aa58
Autor:
A. V. Rudakova, D. M. Danilenko, D. A. Lioznov, L. S. Karpova, S. M. Kharit, E. V. Mikitenko, A. N. Uskov, A. S. Kolbin, L. N. Konovalova, Yu. V. Lobzin
Publikováno v:
Журнал инфектологии, Vol 11, Iss 1, Pp 92-97 (2019)
According to requirements of WHO, the trivalent influenza vaccines (TIV) have to contain antigens of two influenza A strains (A/H1N1, A/H3N2) and one influenza B strain which can be presented by antigens of a virus of lineages Yamagata or Victoria. I
Externí odkaz:
https://doaj.org/article/0cf0e1fcd14f46e5b7d60c13812f894f
Autor:
A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, S. N. Avdeev, G. L. Ignatova, M. P. Kostinov, I. S. Koroleva, R. V. Polibin, I. V. Fomin
Publikováno v:
Журнал инфектологии, Vol 10, Iss 3, Pp 11-22 (2018)
Vaccination against pneumococcal infections by 13-valent conjugate vaccine (PCV13) can significantly reduce morbidity and mortality.The study has been aimed to evaluate the social and pharmacoeconomic aspects of PCV13 vaccination of 65-year-old patie
Externí odkaz:
https://doaj.org/article/a6a5651bda8540e8a82d67b595fbb617